BPC-157: Body-Protective Peptide — Mechanism & Evidence
Educational Content Only
The information on this page is based on scientific publications and is for educational purposes only. It does not constitute medical prescription, diagnosis, therapeutic guidance, or recommendation for use. Any clinical intervention must be individualized by a qualified healthcare professional.
⚠️ The information on this page is based on scientific publications and is for educational purposes only. It does not constitute medical prescription, diagnosis, therapeutic guidance, or recommendation for use. Any clinical intervention must be individualized by a qualified healthcare professional.
Scientific analysis of BPC-157: tissue regeneration mechanism, animal model studies, musculoskeletal and gastrointestinal applications described in literature.
Mechanism of Action
BPC-157 (Body Protective Compound-157) is a pentadecapeptide (15 amino acids) derived from a protein sequence found in human gastric juice. It exhibits an unusual range of actions, working on multiple signaling pathways related to healing, neuroprotection and inflammatory modulation.
1. VEGF pathway activation and angiogenesis
Studies demonstrate that BPC-157 upregulates VEGF (Vascular Endothelial Growth Factor) expression and its receptors, promoting local angiogenesis — a fundamental process in tissue healing. This property has been documented in tendons, muscles, and gastrointestinal mucosa.
2. FAK-paxillin pathway modulation
BPC-157 activates the FAK (Focal Adhesion Kinase) and paxillin pathway, regulating fibroblast migration and proliferation — key cells in collagen synthesis and tissue remodeling. This action contributes to the accelerated healing documented in experimental models.
3. NO system modulation and gastrointestinal protection
BPC-157 interacts with the nitric oxide (NO) system, which participates in both vasodilation and mucosal protection. In rodent studies, it demonstrated ability to protect gastric mucosa against NSAID-, ethanol- and ischemia-induced injuries.
- •Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- •Active via oral and systemic route in animal models
- •No significant homology with known human hormones
Applications Described in Literature
Tendon and ligament healing
Moderate evidenceSeveral rodent studies document accelerated healing of Achilles tendon, anterior cruciate ligament and muscle injuries after BPC-157 administration. Researchers observe increased collagen and VEGF expression, with histological and functional improvement in the models studied.
Gastrointestinal mucosal protection
Moderate evidenceThis is one of the applications with the largest experimental database. Studies describe protection against NSAID-, ethanol-, and stress-induced gastric ulcers. The mechanism involves mucosal VEGF upregulation, NO system modulation, and preservation of epithelial integrity.
Neuroprotection and CNS/PNS injuries
Preliminary evidenceExperimental models of spinal cord injury, peripheral neuropathy and brain trauma demonstrate neuroprotective effects of BPC-157, with documented functional improvement. Proposed mechanisms include modulation of VEGF, NO and dopaminergic/serotonergic systems. Human data are non-existent to date.
Relevant Studies
3 curated studies · 1997–2011
Peer-reviewed evidence with PMID verifiable on PubMed
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease
Sikiric P, Seiwerth S, Brcic L, et al. · Journal of Physiology — Paris
Review of BPC-157 effects in inflammatory bowel disease models, documenting reduced inflammation and improved mucosal integrity in animal models.
BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, wound healing
Sikiric P, Seiwerth S, Rucman R, et al. · Current Pharmaceutical Design
Analysis of BPC-157 angiogenic mechanisms, with comparison to VEGF and other growth factors. Documents FAK-paxillin and VEGFR2 pathway activation.
Hepatoprotective effect of BPC 157
Bilic I, Zoricic I, Anic T, et al. · Digestive Diseases and Sciences
Rodent study demonstrating BPC-157 hepatic and gastrointestinal protection against damaging agents, with mechanism related to the NO pathway.
Latest literature review: 2026-04 · PubMed
FAQ
What is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a gastric protective protein. Animal model studies describe regenerative activity in musculoskeletal, tendinous and gastrointestinal tissues via multiple signaling pathways, including NO, VEGF and growth hormone receptors.
Does BPC-157 have human studies?
Most available evidence on BPC-157 comes from animal model studies. Early clinical phase studies have been published for gastrointestinal indications. Extrapolation to humans should be done with caution and always with individualized professional assessment.
Access the Full Content
Unlock the advanced scientific guide for BPC-157
- Protocols described in scientific literature
- Dose ranges observed in clinical studies
- Associations with other peptides and supplements
- Educational clinical comparisons
- Monitoring and follow-up parameters
- Educational calculators and simulators
Total: US$ 2.49
Valid for 1 year
Secure checkout via Hotmart
or get full access to all peptides
View Full Plan →⚠️ Exclusively educational content. Does not constitute medical prescription.